4//SEC Filing
Axovant Sciences Ltd. 4
Accession 0001209191-17-029474
CIK 0001636050operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 9:07 PM ET
Size
9.9 KB
Accession
0001209191-17-029474
Insider Transaction Report
Form 4
OLANOFF LAWRENCE S
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-04-28+27,000→ 27,000 totalExercise: $24.24Exp: 2027-04-28→ Common Shares (27,000 underlying)
Footnotes (2)
- [F1]100% of this option will vest one year after the date of grant. The option allows for early exercise, subject to the issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F2]Includes only options with the same termination date.
Issuer
Axovant Sciences Ltd.
CIK 0001636050
Entity typeoperating
Related Parties
1- filerCIK 0001636050
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 9:07 PM ET
- Size
- 9.9 KB